Chester County News and Community Website
KING OF PRUSSIA, PA — XyloCor Therapeutics has dosed the first patient in its Phase 2b EXACT-2 trial evaluating XC001 (encoberminogene rezmadenovec), a novel gene therapy designed to help patients …
XyloCor Doses First Patient in Pivotal Gene Therapy Trial for Refractory Angina Read More WAYNE, PA, and TULLINGE, Sweden — XyloCor Therapeutics, Inc. recently secured licensing rights to the Extroducer® Infusion Catheter System from SmartWise. This innovative device is set to revolutionize the delivery …
XyloCor Therapeutics and SmartWise Team Up to Enhance Gene Therapy Delivery Read More WAYNE, PA, and TULLINGE, Sweden — XyloCor Therapeutics, Inc. has signed a licensing agreement with SmartWise to use the Extroducer Infusion Catheter System. This endovascular device is designed to deliver …
XyloCor Therapeutics Licenses SmartWise Device for Advanced Heart Therapy Delivery Read More WAYNE, PA — XyloCor Therapeutics, Inc. recently revealed the final results from the Phase 2 segment of its EXACT clinical trial at the Society for Cardiovascular Angiography & Interventions (SCAI) …
XyloCor Therapeutics Announces Promising Results for Gene Therapy in Treating Refractory Angina Read More